• VERTEX PHARMACEUTICALS INC Financial Overview

  • Income Statement: VRTX

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 199.01 M 216.36 M -17.34 M -8.72%
    Gross Profit 157.65 M 178.32 M -20.67 M -13.11%
    Net Income Before Extra Items/Preferred Div -391.28 M -206.89 M -184.39 M 47.12%
    Operating Income -412.67 M -225.39 M -187.29 M 45.38%
  • Cash Flow: VRTX

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing -10.19 M 365.86 M -376.06 M 3,690.43%
    Net Cash Flow - Investing -405.17 M 208.47 M -613.64 M 151.45%
    Net Cash Flow/Operating Activities -252.48 M -22.48 M -230.00 M 91.10%
  • Balance Sheet: VRTX

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 601.48 M 921.58 M -320.10 M -53.22%
    Total Liabilities 330.18 M 415.64 M -85.46 M -25.88%
    Shareholders Equity 271.30 M 505.94 M -234.64 M -86.49%
  • Key Ratios / Statistics: VRTX

    • Valuation

      Price/Earnings (TTM) -7.67
      Price/Sales (TTM) 15.06
      Price/Book (MRQ) 19.69
      Price/Cash Flow (TTM) -12.33
    • Profitability

      Gross Margin 79.22
      Operating Margin -207.36
      Profit Margin -196.61
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 2.47
      Current Ratio (MRQ) 4.69
      Long Term Debt-to-Equity (MRQ) 119.83
    • Management Effectiveness

      Return on Equity (TTM) -100.11
      Return on Assets (TTM) -43.44
      Return on Investments (TTM) -84.83